Definitive Contract 140D0426C0012
- Not listed
- The National Institutes of Health awarded a $600,000 firm fixed-price definitive contract to Heliowave Technologies Inc., a small disadvantaged business based in College Station, Texas, to develop cell and gene therapy process analytical technology and quality control testing solutions. The contract, awarded on February 26, 2026, with an ultimate completion date of March 31, 2027, is set aside for total small business participation. Heliowave Technologies specializes in advanced microfluidic and...
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Quality Biological Inc., a minority-owned, self-certified small disadvantaged business located in Gaithersburg, Maryland. The purpose of this $25,374,525.00 contract is to support the activities required to produce, procure, store, ship, and maintain high-quality reagents, assays, and services in support of...
- This is a $21,208,581.76 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Quality Biological Inc., a self-certified small disadvantaged business. The contract has a total small business set-aside designation and an ultimate completion date of April 7, 2025. Quality Biological Inc., through its Quality Biological, Inc. division, is a minority-owned...
- The National Institutes of Health Office of Logistics and Acquisition Operations awarded a $12,802.86 firm fixed price Blanket Purchase Agreement call to Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business located in Gaithersburg, Maryland. This contract, awarded on September 1, 2021, with an ultimate completion date of November 30, 2021, does not utilize a set-aside designation. The award supports the procurement of chemicals and laboratory supplies essential...
- The National Institutes of Health (NIH) Office of Logistics and Acquisition Operations awarded a Firm Fixed Price BPA Call contract to Quality Biological Inc. on October 18, 2021, for laboratory supplies with a ceiling value of $18,900.04 and an ultimate completion date of November 30, 2021. This award was issued without a set-aside designation, reflecting the contractor's competitive standing in the federal marketplace. Quality Biological Inc., a woman-owned, minority-owned small...
- The U.S. National Institutes of Health (NIH) Office of Logistics and Acquisition Operations awarded Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business, a $12,648.95 firm fixed-price BPA call for laboratory supplies. The award, issued on November 5, 2018, with an ultimate completion date of November 30, 2018, was made without a set-aside designation, reflecting the vendor's competitive standing in the federal marketplace. Quality Biological Inc., based in...
- This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
- The National Institutes of Health's Office of Logistics and Acquisition Operations awarded a firm fixed price contract to Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business based in Gaithersburg, Maryland, for the supply of chemicals. This $22,120.18 Blanket Purchase Agreement call was awarded on February 15, 2022, with an ultimate completion date of November 30, 2022. No set-aside designation was applied to this award, reflecting the contractor's competitive...
- The National Institutes of Health's Office of Logistics and Acquisition Operations awarded a firm fixed price contract call valued at $15,336.32 to Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business based in Gaithersburg, Maryland. The contract, awarded on February 11, 2019 with an ultimate completion date of November 30, 2019, covers laboratory supplies to support NIH research initiatives. This award represents a call against Quality Biological Inc.'s existing...
- The National Institutes of Health (NIH) Office of Logistics and Acquisition Operations awarded a Blanket Purchase Agreement (BPA) call contract valued at $20,023.08 to Quality Biological Inc. for laboratory supplies. The award was issued on January 10, 2022, with an ultimate completion date of November 30, 2022, under a firm fixed-price pricing model. The contract contains no set-aside designation, reflecting Quality Biological Inc.'s competitive standing as a woman-owned, minority-owned small...
The National Institutes of Health awarded a $600,000 firm fixed-price contract to Quantitative Biosciences, Inc., a San Diego-based small business, for cell and gene therapy process analytical technology and quality control testing. The contract was awarded on February 26, 2026, with an ultimate completion date of March 31, 2027, under a total small business set-aside designation. This effort supports the NIH's mission to advance biomedical research by developing critical analytical and quality control capabilities for cell and gene therapy manufacturing, which are emerging therapeutic modalities requiring sophisticated process characterization and quality assurance methodologies. Quantitative Biosciences specializes in biosensor development and advanced analytical technologies, leveraging expertise in microfluidic platforms, neural network-based processing, and detection systems. The company has established itself as a federal contractor through multiple awards from agencies including the Defense Advanced Research Projects Agency, the Naval Information Warfare Systems Command, and the Environmental Protection Agency, with prior contract values ranging from $100,000 to approximately $4 million. This NIH contract aligns with the company's demonstrated capabilities in developing sensitive detection and monitoring technologies, which will be applied to the specialized requirements of cell and gene therapy process analytics and quality control.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $600.0k | 2/25/26 |